Mark S. Levine, Chief Legal Officer at Immunovant, Inc. (IMVT), sold 5,720 shares at $28.79 ($165K) on 2024-10-16, disclosed to the SEC on 2024-10-18.
Open-market sale of $165k IMVT by Chief Legal Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.79 | 2,860 | $82K | 50.0% |
| 2 | $28.79 | 2,860 | $82K | 50.0% |
| Total | $28.79 avg | 5,720 | $165K | 100% |
| Filing → |
| IMVT | SELL | 2024-08-23 | $206K | — | Filing → |
| IMVT | SELL | 2024-07-26 | $223K | — | Filing → |
| IMVT | SELL | 2024-07-19 | $144K | — | Filing → |